Annually the UK Kidney Association awards highly prestigious named lectures that are given at its annual conference, UK Kidney Week® (UKKW):

  • Chandos Lecture
  • De Wardener Lecture
  • Donna Lamping Lecture
  • O'Donoghue Lecture
  • Osman Lecture
  • Stewart Cameron Lecture

Award Process

A call for nominations and nomination form will be sent to the UKKA Members.

Members are asked to submit nominations of 100 words, indicating:

  • the topic area and lecturer
  • why the lecturer is authoritative on the topic
  • the qualities the lecturer has – has the Member heard the individual speak before, etc.

Nominations will be reviewed by an appropriate and balanced appointments panel.

The Panel makes its recommendation based on the merit of each applicant and in line with the criteria for each named lecture. Final decisions will be based on:

  • range of topics over several years
  • balance of programme for the coming UKKW Programme including:
    • mix of international and national speakers
    • diversity – following the UKKA diversity policy

The decision is ratified by the Trustee Board.

Unsuccessful nominees may be re-submitted in future years.

Chandos Lecture

The Chandos Lecture of the UK Kidney Association was established in 1976 with the support of the National Kidney Research Fund (NKRF), now Kidney Research UK.

The Chandos family have given great support to the kidney community in this country over many years. The Honourable Anthony Lyttleton, the second Viscount Chandos, developed kidney failure in the 1960s and was treated by dialysis and subsequently received a kidney transplant at Charing Cross Hospital under Professor Hugh de Wardener. Lord Chandos hosted the launch of NKRF at Westminster in 1966, and, until his death, continued to use his considerable influence to promote the issues of kidney disease and kidney care in high places.

The Chandos Lecture is given at the UKKA Annual Conference, UK Kidney Week. Applications are open to UKKA members and are warmly encouraged by UK and international nephrologists, renal scientists and members of the multi-professional team and can cover any topic related to kidney disease.

  • 1976 – Larry Earley (USA) – The development of the concept of control of sodium reabsorption by physical factors
  • 1978 – Charles Cochrane (USA) – Mediation of glomerular injury
  • 1980 – Barry Brenner (USA) – The physiological basis of glomerular filtration
  • 1982 – Michael Mauer (USA) – The glomerular mesangium in diabetic nephropathy
  • 1986 – Saulo Klahr (USA) – The effects of urinary obstruction
  • 1988 – Ramzi Cotran (USA) – Endothelial activation in vascular injury
  • 1991 – Herman Waldmann (UK) – Prospects for transplantation tolerance
  • 1992-5 – No lecturers appointed
  • 1996 – Marc de Broe (Belgium) – Recovery from injury to the kidney
  • 1998 – Stuart Shankland (USA) – The role of cell cycle proteins in glomerular disease
  • 2000 – Mark Pepys (UK) – Prognostic and pathogenetic significance of C-reactive protein
  • 2002 – Peter Ratcliffe (UK) – Oxygen sensing
  • 2004 – Ram Gokal (UK) – Peritoneal dialysis
  • 2006 – No lecturers appointed
  • 2007 – Steve Harper (UK) – How the glomerulus works in health and disease – or so you thought
  • 2008 – No lecturers appointed
  • 2009 – Dontscho Kerjaschki (Austria) – Podoplanin – from podocytes and beyond
  • 2010 – Rob Horne (UK) – Supporting behaviour changes in patients with chronic kidney disease
  • 2011 – Fred Finkelstein (USA) – Quality of life on dialysis: The Patients’ Perspective
  • 2012 – Gerry Appel (USA) – What have we learned about the treatment of Lupus Nephritis
  • 2013 – No lecturers appointed
  • 2014 – No lectures appointed
  • 2015 – Ken Farrington (UK) – End-of-life and palliative care in the dialysis setting
  • 2016 – Liz Lightstone (UK) – Pregnancy and Kidney Disease: the 3Ps
  • 2017 – Simon Davies (UK) – Can we control volume sufficiently in anuric patients?
  • 2018 – Menna Clatworthy (UK) – Life in the marshes – kidney environment shapes immune cell function
  • 2019 – Albert Ong (UK) – Reimagining clinical care in ADPKD for the 21st century?
  • 2020 - No lecturer appointed
  • 2021 - Megan Griffith (UK) - Update in membranous glomerulonephritis
  • 2022 - No lecturer appointed
  • 2023 - No lecturer appointed
  • 2024 - John Sayer (UK) - Unveiling urinary phenotypes: strategies for kidney disease diagnosis and treatment

De Wardener Lecture

The de Wardener lecture was established in 2004 in honour of Professor Hugh de Wardener (1915-2014), one of the UK’s most distinguished nephrologists and clinical scientists. He was President of both the Renal Association [1974-77] and the International Society of Nephrology [1969-72].

The first lecture was given by Professor de Wardener himself. From 2006 it became a regular feature of the Renal Association Annual Conference, and chosen lecturers have a distinguished record in clinical research related to kidney disease.

  • 2004 – Hugh de Wardener (UK) – Plasma sodium and hypertension
  • 2005 – Graham MacGregor (UK) – Salt – Neptune’s gift?
  • 2006 – Bryan Williams (UK) – The hypertensive heart
  • 2007 – Pierre Ronco (France) – New insights into the pathophysiology of membranous nephropathy: a bench-to-bedside story
  • 2008 – Richard J Johnson (USA) – Uric acid, the metabolic syndrome and kidney disease
  • 2009 – Tim Goodship (UK) – Haemolytic Uraemic Syndrome
  • 2010 – Barry Freedman (USA) – New genetic insights in end-stage renal disease
  • 2011 – Hans Oberleithner (Germany) – Sodium: Wolf in Sheep’s Clothing
  • 2012 – Peter Mathieson (UK) – Towards rational therapy for proteinuria
  • 2013 – Terry Cook (UK) – Conventional and molecular microscopy in renal transplant pathology
  • 2014 – Neil Turner (UK) – Alports and the structure of the glomerulus
  • 2015 – David Jayne (UK) – B-cell targeting in ANCA-associated vasculitis
  • 2016 – Adrian Woolf (UK) – Kidney and urinary tract malformations: from the clinic to understanding molecular mechanisms and envisioning novel therapies
  • 2017 – David Wheeler (UK) – Sweetening the urine: A new approach to the management of chronic kidney disease
  • 2018 – Moin A Saleem (UK) – Stratified medicine in Nephrology
  • 2019 – Edwina Brown (UK) – Individualising the peritoneal dialysis prescription
  • 2020 - No lecturer appointed
  • 2021 - Rachel Lennon (UK) - Investigating basement membrane biology to improve treatments for Alport syndrome
  • 2022 - No lecturer appointed
  • 2023 - Laurie Tomlinson (UK) - Filling in the gaps & beyond
  • 2024 - No lecturer appointed

Donna Lamping MDT Researcher Award

The Donna Lamping Award was set up to celebrate the contribution of multi-professional research in improving patient care and was historically awarded to the grant holder of a joint British Renal Society and Kidney Care UK grant.

Professor Donna Lamping, originally from Canada, moved to the UK in 1992 where she brought her cutting-edge knowledge of assessment for how patients' health and quality of life could be measured. Her work focussed on the behavioural impact of chronic illness, initially focussing on people with chronic kidney disease.

Nominations are open to UKKA members who have contributed to outstanding research in kidney care.

2012 - Joseph Chilcott - Understanding depression and illness perceptions in ESRD: Time for intervention

2013 - Paula Ormandy - Patient information need, the foundation for information provision, education and decision making

2014 - Maria Da Silva Gane - End of Life Care

2015 - Chris Jones - Renal Replacement Therapy in the increasingly elderly

2016 - Elizabeth Lindley - The cost of neglecting residential renal function in haemodialysis patients

2017 - Sharlene Greenwood - Renal exercise research: Are we there yet?

2018 - Nicola Thomas - The how and the why of patient and public involvement in research

2019 - Enric Vilar - Individualising Haemodialysis

2020 - No lecturer appointed

2021 - Lina Johansson - My clinical academic journey: 6 lessons learnt during my research career

2022 - No lecturer appointed

2023 - Helen Noble - Renal Arts Group – Improving quality of life through art

2024 - Sharon Huish - Overcoming the PhD stereotype; Empowering multidisciplinary teams for research success

O’Donoghue Lecture

Professor Donal O’Donoghue was a clinical nephrologist and the first National Clinical Director for Kidney Care for England. A passionate advocate on behalf of people with kidney disease, he became a leading force driving the development of effective nephrology services in the UK and beyond. He tragically died suddenly when still at the height of his professional career. He served the Renal Association as Treasurer (2003-2006) and then President (2016-2018). During his Presidency, he led a re-structuring of the Association, with careful attention to governance, financial prudence, and diversity. He encouraged involvement of trainees and early years consultants in the Renal Association. The initial steps were taken to create a single and truly multi-professional UK kidney society, which eventually became the UK Kidney Association. In 2018 he became chair of the International Society of Nephrology Advocacy Working Group, a role ideally matched to his unique experience of interaction with governments and health system managers, his determination to ensure the patient voice remained at the centre of health professional work, and his passion for advancing global kidney health in every setting. Other leadership roles reflected his wide concerns for clinical service development, for the support of the workforce, and for patients and their carers. He was President of the British Renal Society (representing the multi-professional kidney team) from 2000-2003, and at the time of his death was chair of the patient support charity Kidney Care UK. For his services to kidney patients, he became OBE in 2018.

Applications are open to UKKA members and are warmly encouraged by UK and international nephrologists, renal scientists and members of the multi-professional team and can cover any topic related to renal healthcare policy, training or workforce planning.

2021 - Chris Whitty - The role of the medical profession in tackling UK health disparities

2022 - June Raine

2023 - Phil Kalra - Building careers together through academic advancement

2024 - Sharlene Greenwood - It takes a village

Osman Lecture

The Osman Lecture of the UK Kidney Association was endowed by Mrs Ruth Osman, widow of Dr Arnold Osman, who was a founding member and the first President of the Renal Association who died in 1972.

The Osman Lecture is given at the UKKA Annual Conference, UK Kidney Week. Applications are open to UKKA members and are warmly encouraged by UK and international nephrologists, renal scientists and members of the multi-professional team and can cover any topic related to kidney disease.

  • 1975 – David Baldwin (USA) – Post-streptococcal glomerulonephritis and the end-stage kidney
  • 1977 – David Kerr (UK) – Renal bone disease: the effects of dialysis and transplantation
  • 1979 – Jonas Bergstrom (Sweden) – Uraemic toxicity
  • 1981 – Hugh de Wardener (UK) – Naturiuretic hormone
  • 1984 – Robert Schrier (USA) – The cell biology of ichaemia
  • 1985 – Netar Mallick (UK) – Sapient glomerulopathies, or how far since Ellis?
  • 1987 – Philip Hoedemaeker (Netherlands) – New developments in experimental glomerulonephritis
  • 1990 – Andrew Rees (UK) – Rapidly progressive glomerulonephritis: from pathogenesis to treatment
  • 1991-4 – No lecturers appointed
  • 1995 – Gerry Coles (UK) – CAPD – a critique
  • 1997 – Robert Lechler (UK) – Overcoming the obstacle to successful long-term transplantation
  • 1999 – Nick Hastie (UK) – Wilm’s tumour – a case of abnormal nephrogenesis: multiple roles for the Wilm’s tumour suppressor WT1
  • 2001 – Norbert Lamiere (Belgium) – Disaster nephrology
  • 2003 – Jeffrey Platt (USA) – New insights into autoimmunity
  • 2005 – No lecturers appointed
  • 2006 – Peter Mathieson (UK) – Focal segmental glomerulosclerosis
  • 2007 – No lecturers appointed
  • 2008 – Juergen Floege (Germany) – From cage to bedside: new approaches to the treatment of CKD patients
  • 2009 – Andy Rees (Austria) – Small vessel vasculitis – from humans to experimental models and back again
  • 2010 – David Salant (USA) – The antigenic target in membranous nephropathy
  • 2011 – Myles Wolf (USA) – Role of FGF23 in Adverse Clinical Outcomes in CKD
  • 2012 – Fiona Karet (UK) – Chasing Tails: Clinic to C-terminus
  • 2013 – John Feehally (UK) – Global Nephrology
  • 2014 – Caroline Savage (UK) – How can industry and academia collaborate to deliver clinical research?
  • 2015 – Robert Kleta (UK) – Renal Fanconi syndromes
  • 2016 – Claire Sharpe (UK) – New therapeutic targets in renal fibrosis, how do we jump the barrier to clinical translation?
  • 2017 – Paul Brenchley (UK) – What is new in Membranous Nephropathy?
  • 2018 – No lecturers appointed
  • 2019 – Charles Pusey (UK) – a Lifetime in vasculitis research
  • 2020 - Sir Peter Ratcliffe (UK)
  • 2021 - No lecturers appointed
  • 2022 - No lecturers appointed
  • 2023 - Angela Webster (AUS) - Data integration and synthesis for equitable kidney care
  • 2024 - No lecturer appointed

Stewart Cameron Lecture for Outstanding Contribution to the Basic Scientific Understanding of Kidney Disease

This prestigious annual award has been established in memory of Stewart Cameron, former Professor of Renal Medicine at Guy’s Hospital and President of the UK Renal Association, European Renal Association, and International Society of Nephrology, following his death in 2023.

The honour of presenting the Stewart Cameron Lecture of the UK Kidney Association will be awarded to a non-clinical basic scientist whose work has contributed significantly to kidney disease research. The typical awardee will be at Senior Lecturer level or below.

Instructive criteria for the review of nominations will include, but not be limited to, evidence of:

  • publications of experimental data in high impact factor journals
  • integration of basic science and clinical care to translate experimental findings with the aim of improving outcomes for people with kidney disease
  • leadership and direction of the research agenda within the nominee’s respective field

2024 - Laura Denby